Drug Discovery & Development
5 takeaways from the Cell & Gene Meeting on the Mesa
In this final episode of our coverage from the 2021 Cell & Gene Meeting on the Mesa, hosted by the Alliance for Regenerative Medicine, ScienceBoard.net Editor-in-Chief, Samantha Black, PhD, discusses five takeaways from the event. Read More
Cytek launches new immunoprofiling assay
Cytek Biosciences has launched a 25-color immunoprofiling assay optimized for its flagship Aurora cell analysis systems. Read More
AI drug development market projected to reach $5.1B by 2025
The world market for AI applications in drug development is projected to reach $5.1 billion by 2025, an increase of more than $3.6 billion from the market size in 2020. However, significant challenges are lurking ahead as the industry enters the next phase, according to Ulrik Kristensen, PhD, of Emersion Insights. Read More
Learning from older drug modalities accelerates viral process development
Andrew Tustian, EngD, director of viral process development at Regeneron Pharmaceuticals, spoke with ScienceBoard.net about accelerating process development for adeno-associated viruses by modifying strategies from older modalities. Read More
New 4D visualization shows epigenetic processes unfold over time
Scientists have developed a new visualization method to construct 4D models of X chromosome inactivation, lending insight into gene expression and opening new pathways to drug treatments for gene-based disorders and diseases. The findings are being published on October 8 in the Proceedings of the National Academy of Sciences of the United States of America. Read More
How one company aims to make bedside cell therapies a reality
SQZ Biotech is developing high-throughput technology that can manufacture novel cell therapy products in under 24 hours. Founder and CEO Armon Sharei, PhD, spoke with ScienceBoard.net recently at Biotech Week Boston 2021. Read More
Cancer Cell Map Initiative reveals protein interactions that drive cancer
A research group has mapped previously unknown interactions between proteins that drive cancer, thereby revealing potential new biomarkers and drug targets. The findings were published in a trio of papers in Science on October 1. Read More
5 ways social media can make drug development more patient-centered
Insights gleaned from analyzing social media can facilitate patient-centered drug development and help spur innovation in drug discovery, according to a paper published online recently in Drug Discovery Today. Read More
Venture Lab selects early-stage companies for accelerator program
The BioInnovation Institute has named the first cohort of early-stage companies participating in its Venture Lab startup accelerator program. Seven ventures have been selected across three specialized areas: therapeutics, bioindustrials, and health technology. Read More
Vaccine for tooth decay? It's not science fiction, says NIH
A vaccine for caries could be possible under a new division of the U.S. National Institutes of Health (NIH) that has been tasked with using "crazy, bold ideas" to prevent and cure disease. Health leaders introduced the proposed agency at a September 9 meeting of the National Institute of Dental and Craniofacial Research. Read More
Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter